Correction to: Is the Availability of Biosimilar Adalimumab Associated with Budget Saving? A Difference-in-Difference Analysis of 14 Countries.
Hyunjung WooGyeongseon ShinDonghwan LeeHye-Young KwonSeung Jin BaePublished in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)